Matthew Gillmor
Stock Analyst
(n/a)
# 4,406
Out of 4,412 analysts
19
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Upgrades: Outperform | n/a | $13.01 | - | 8 | Nov 13, 2020 | |
| MDRX Veradigm | Downgrades: Neutral | n/a | $7.96 | - | 3 | Oct 19, 2020 | |
| PHR Phreesia | Maintains: Outperform | n/a | $20.61 | - | 2 | Apr 24, 2020 | |
| MD Pediatrix Medical Group | Maintains: Neutral | n/a | $9.04 | - | 1 | Apr 21, 2020 | |
| HSTM HealthStream | Downgrades: Neutral | n/a | $25.61 | - | 2 | Jun 14, 2018 | |
| EVH Evolent Health | Maintains: Outperform | n/a | $27.65 | - | 2 | Sep 28, 2017 | |
| MMS Maximus | Initiates: Neutral | n/a | $80.43 | - | 1 | Sep 1, 2017 |
Teladoc Health
Nov 13, 2020
Upgrades: Outperform
Price Target: n/a
Current: $13.01
Upside: -
Veradigm
Oct 19, 2020
Downgrades: Neutral
Price Target: n/a
Current: $7.96
Upside: -
Phreesia
Apr 24, 2020
Maintains: Outperform
Price Target: n/a
Current: $20.61
Upside: -
Pediatrix Medical Group
Apr 21, 2020
Maintains: Neutral
Price Target: n/a
Current: $9.04
Upside: -
HealthStream
Jun 14, 2018
Downgrades: Neutral
Price Target: n/a
Current: $25.61
Upside: -
Evolent Health
Sep 28, 2017
Maintains: Outperform
Price Target: n/a
Current: $27.65
Upside: -
Maximus
Sep 1, 2017
Initiates: Neutral
Price Target: n/a
Current: $80.43
Upside: -